V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290004447 | 290006486 | 1.63 | 51.1 | Adjuvant (A) | 2014-08-20 | 2014-08-20 | OCTREOTIDE | N | N | 290021208 | CAPECITABINE |
| 290004448 | 290006486 | 1.6 | 87.1 | Adjuvant (A) | 2017-01-24 | 2017-02-11 | CETUXIMAB + RT | 2 | N | 290021208 | IRINOTECAN + MDG |
| 290004449 | 290006486 | 1.7 | 87.1 | Neo-adjuvant (N) | 2015-09-11 | 2015-09-25 | Capecitabine 42days + RT | N | N | 290021208 | CARBOPLATIN + ETOPOSIDE |
| 290004450 | 290006486 | 1.65 | 59.7 | Palliative (P) | 2013-12-21 | 2014-01-14 | Irinotecan + Modified De Gramont | 2 | N | 290021208 | Y-90 |
| 290004451 | 290003269 | 0 | 84.3 | Palliative (P) | 2018-02-25 | 2018-03-31 | Capecitabine | N | N | 290021215 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004452 | 290006487 | null | null | Disease modification (D) | null | 2018-05-03 | Y-90 | N | N | 290021217 | CAPECITABINE + RT |
| 290004453 | 290003270 | 1.51 | 63 | Curative (C) | 2016-03-05 | 2016-03-05 | Cisplatin +Fluorouracil (3 wk) | 02 | Y | 290021219 | IDARUBICIN |
| 290004454 | 290003270 | 1.61 | 71 | Curative (C) | 2016-04-02 | 2016-04-30 | Cetuximab + Radiotherapy Load | 02 | Y | 290021219 | CISPLATIN + FLUOROURACIL |
| 290004455 | 290003271 | 1.55 | 0 | Palliative (P) | 2013-11-15 | 2013-11-15 | EOX | 02 | N | 290021226 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004456 | 290003272 | 1.71 | 86.7 | Palliative (P) | 2014-11-27 | 2014-11-29 | Carboplatin + Pemetrexed | N | N | 290021227 | CARBO + FLUOROURACIL |
| 290004457 | 290003273 | 1.83 | 75.2 | Curative (C) | null | 2013-09-27 | Capecitabine + Cisplatin | Y | Y | 290021229 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004458 | 290003274 | 1.81 | 97 | Palliative (P) | 2017-02-13 | 2017-02-13 | OCTREOTIDE | 02 | null | 290021230 | CAPECITABINE + RT |
| 290004459 | 290003275 | 1.7 | null | Curative (C) | 2016-08-05 | 2016-08-15 | Y-90 | null | Y | 290021231 | CAPECITABINE |
| 290004460 | 290003276 | 0 | 81.8 | Palliative (P) | null | 2014-04-14 | Capecitabine + Cisplatin + RT | N | N | 290021232 | CAPECITABINE + GEMCITABINE |
| 290004461 | 290003277 | 1.68 | 71.1 | Neo-adjuvant (N) | 2015-04-18 | 2015-04-19 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 290021234 | RUXOLITINIB |
| 290004462 | 290003278 | 1.56 | 78 | Curative (C) | 2014-11-29 | 2014-12-31 | LANREOTIDE | 02 | Y | 290021235 | EVEROLIMUS |
| 290004463 | 290003279 | 1.54 | 64.8 | Curative (C) | 2014-11-01 | 2014-11-02 | Fluorouracil 96hr infusion+R(4g/m2) | 02 | null | 290021237 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 290004464 | 290003280 | 1.73 | 54 | Curative (C) | 2017-12-18 | 2018-01-01 | CAPECITABINE + RT | N | N | 290021239 | IRINOTECAN + MDG |
| 290004465 | 290003281 | 1.75 | 64.6 | Disease modification (D) | 2013-11-01 | 2013-11-28 | Docetaxel 75mg/m2 (21 day) | N | N | 290021240 | TCF |
| 290004466 | 290003282 | 1.65 | 69 | Disease modification (D) | 2015-01-31 | 2015-02-16 | Irinotecan + Modified De Gramont | 2 | N | 290021241 | TRIAL |
| 290004467 | 290003282 | 0 | null | null | 2016-03-30 | 2016-04-27 | Enzalutamide | Y | Y | 290021241 | CAPECITABINE |
| 290004468 | 290003283 | 1.56 | 56.6 | Palliative (P) | 2015-07-15 | 2015-07-18 | Trial Unspecified | N | N | 290021243 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 290004469 | 290003283 | 1.79 | 64 | null | 2016-04-15 | 2016-04-27 | Folfirinox | 2 | null | 290021243 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004470 | 290003284 | 1.77 | 0 | Curative (C) | null | 2014-06-24 | CAPECITABINE + TEMOZOLOMIDE | N | Y | 290021248 | ECX |
| 290004471 | 290003285 | 1.77 | 51.2 | Neo-adjuvant (N) | null | 2013-07-20 | Cisplatin + Etoposide po&iv 3 day | N | Y | 290021250 | CISPLATIN + FLUOROURACIL |
| 290004472 | 290003286 | 1.7 | 56.3 | Palliative (P) | 2016-12-26 | 2017-01-15 | Capecitabine + Streptozocin | 2 | N | 290021252 | PACLITAXEL |
| 290004473 | 290003287 | 1.6 | null | Palliative (P) | 2014-12-12 | 2014-12-13 | LANREOTIDE | 02 | null | 290021253 | CAPECITABINE + STREPTOZOCIN |
| 290004474 | 290003288 | 1.6 | 76.35 | Palliative (P) | 2014-03-06 | 2014-03-06 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290021255 | GEMCITABINE |
| 290004475 | 290003288 | null | 65 | Palliative (P) | 2013-12-30 | 2013-12-30 | Docetaxel | N | N | 290021255 | TRIAL |
| 290004476 | 290003289 | 1.79 | 84.9 | Palliative (P) | 2015-06-07 | 2015-06-12 | Cisplatin +Fluorouracil (3 wk) | N | N | 290021259 | ENZALUTAMIDE |
| 290004477 | 290003289 | 1.62 | 62 | Neo-adjuvant (N) | 2014-04-02 | 2014-04-16 | FLUOROURACIL | N | N | 290021259 | CAP |
| 290004478 | 290003289 | 1.6 | 60.5 | Neo-adjuvant (N) | 2016-09-05 | 2016-10-02 | Gemcitabine + Capecitabine | 2 | null | 290021259 | CARBOPLATIN + ETOPOSIDE |
| 290004479 | 290003289 | 1.59 | 64.6 | Not known (9) | 2013-11-21 | 2013-11-21 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | null | 290021259 | CAPECITABINE + RT |
| 290004480 | 290003290 | 1.77 | 85 | Not known (9) | 2014-07-10 | 2014-07-10 | Carboplatin+Fluorouracil 4 or 5 day | 01 | N | 290021269 | IRINOTECAN + MDG |
| 290004481 | 290003291 | 1.51 | 108 | Curative (C) | 2017-01-27 | 2017-02-27 | Irinotecan + Modified De Gramont | N | N | 290021270 | FLUOROURACIL |
| 290004482 | 290003291 | 1.55 | 58 | Adjuvant (A) | 2015-09-24 | 2015-10-14 | Trial Unspecified | N | N | 290021270 | CAPECITABINE |
| 290004483 | 290003291 | null | null | Disease modification (D) | 2014-06-02 | 2014-06-10 | CISPLATIN + FLUOROURACIL | Y | N | 290021270 | CETUXIMAB + RT |
| 290004484 | 290003291 | 1.59 | 62.5 | Disease modification (D) | 2014-07-07 | 2014-07-07 | PACLITAXEL | N | N | 290021270 | Y-90 |
| 290004485 | 290003291 | null | 48.8 | Palliative (P) | 2018-01-14 | 2018-02-05 | LANREOTIDE | null | N | 290021270 | FLUOROURACIL |
| 290004486 | 290003291 | 1.62 | 47 | Palliative (P) | null | 2013-05-24 | Carboplatin + Cetux + FU (>Cycle 2) | N | N | 290021270 | CAPECITABINE |
| 290004487 | 290003292 | 1.68 | 63 | Palliative (P) | 2014-03-05 | 2014-03-05 | Irinotecan + Modified De Gramont | 02 | N | 290021277 | CAPECITABINE + IRINOTECAN |
| 290004488 | 290003293 | 1.92 | 63.5 | null | 2015-05-03 | 2015-05-08 | Bevacizumab 5mg/kg | N | N | 290021281 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004489 | 290003294 | 1.83 | null | Palliative (P) | null | 2017-03-04 | LANREOTIDE | N | N | 290021282 | PLATO TRIAL |
| 290004491 | 290003296 | null | 52.1 | Palliative (P) | 2016-11-01 | 2016-11-08 | Capecitabine | 02 | N | 290021286 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 290004492 | 290003297 | 1.58 | 88 | Palliative (P) | 2013-02-28 | 2013-03-05 | EOX | N | N | 290021289 | INTERAACT TRIAL |
| 290004493 | 290003298 | 1.78 | 86.5 | Adjuvant (A) | null | 2015-06-17 | Capecitabine 35days + RT | N | N | 290021290 | OCTREOTIDE |
| 290004494 | 290003298 | 1.84 | 89.2 | Palliative (P) | 2016-09-24 | 2016-10-25 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290021290 | VDC |
| 290004495 | 290003298 | 1.51 | null | Palliative (P) | 2015-05-20 | 2015-09-21 | Cetuximab 7 day (>Cycle 2) | N | N | 290021290 | CETUXIMAB + IRINOTECAN + MDG |
| 290004496 | 290003299 | 1.49 | 60 | Palliative (P) | 2016-01-22 | 2016-01-23 | CETUXIMAB + RT | 02 | N | 290021293 | CAPECITABINE + CISPLATIN |
| 290004497 | 290003299 | null | 58.05 | Palliative (P) | 2016-04-10 | 2016-04-29 | OCTREOTIDE | N | N | 290021293 | CISPLATIN + FLUOROURACIL |